Status:
COMPLETED
Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19
Lead Sponsor:
Biruni University
Conditions:
Menstrual Problem
Covid19
Eligibility:
FEMALE
18-45 years
Brief Summary
The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovar...
Detailed Description
The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovar...
Eligibility Criteria
Inclusion
- Being between the ages of 18 and 45,
- PCR test result positive confirmed having COVID-19 infection,
- Women had at least one period of Menstrual cycle after COVID-19
- Being an Internet connection,
- To be able to speak and write in Turkish.
Exclusion
- To be in the premenaposual/postmenopausal period (to be in the transition period to menopause or in the period after menopause.)
- Having insufficient co-operation.
Key Trial Info
Start Date :
May 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04806815
Start Date
May 18 2021
End Date
June 1 2021
Last Update
June 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biruni University
Istanbul, Turkey (Türkiye)